Table 6. Pathway enrichment analysis results ('q-value (FDR: BH-method) less than 0.05').
Nº CpG | Pathway Source | Pathway Name | P value | Category | Genes | r2 Adj |
15 | KEGG | Longevity regulating pathway | 2.27E-26 | All | ADCY5, ADCY6, ADCY9, CAMK4, CREB5, FOXO1, IGF1, IGF1R, INS, MTOR, PRKAG2, RELA, RHEB, TSC1, ULK1 | 0 |
12 | KEGG | Longevity regulating pathway | 3.23E-21 | Cholesterol | ADCY6, ADCY9, CAMK4, CREB5, FOXO1, IGF1R, MTOR, PRKAG2, RELA, RHEB, TSC1, ULK1 | 0.072 |
10 | KEGG | Longevity regulating pathway | 8.67E-18 | HOMA-Index | ADCY5, ADCY6, CREB5, FOXO1, IGF1, IGF1R, INS, MTOR, RELA,ULK1 | 0.153 |
12 | KEGG | Longevity regulating pathway | 3.23E-21 | Waist Circumference | ADCY5, ADCY6, CREB5, FOXO1, IGF1, IGF1R, INS, MTOR, PRKAG2, RELA, TSC1, ULK1 | 0.341 |
8 | KEGG | Longevity regulating pathway | 2.30E-14 | Metabolic Syndrome | ADCY5, ADCY6, CREB5, IGF1R, INS, MTOR, RELA, ULK1 | 0.092 |
KEGG: Kyoto Encyclopedia of Genes and Genomes. HOMA: homeostatic model assessment BMI: Body mass index.